Clinical Trial Results: Idiopathic Thrombocytopenic Purpura

Home

Results

This database is populated with information on the results of Roche-sponsored clinical trials.

Product Name: MabThera/Rituxan [rituximab]
Date of Report: To be Published
Phase: III
A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Product Name: MabThera/Rituxan [rituximab]
Date of Report: To be Published
Phase: II
A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.


© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement